Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004259952 | SCV003880640 | uncertain significance | not specified | 2023-02-14 | criteria provided, single submitter | clinical testing | The c.1564G>A (p.E522K) alteration is located in exon 5 (coding exon 5) of the TACC1 gene. This alteration results from a G to A substitution at nucleotide position 1564, causing the glutamic acid (E) at amino acid position 522 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Duke University Health System Sequencing Clinic, |
RCV003223445 | SCV003919086 | uncertain significance | Seizure | 2023-04-20 | criteria provided, single submitter | research |